[HTML][HTML] Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study …
C Grohé, T Wehler, T Dechow, S Henschke… - Translational Lung …, 2022 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) with or without chemotherapy represent first-line
standard of care for patients with advanced non-small cell lung cancer (NSCLC) …
standard of care for patients with advanced non-small cell lung cancer (NSCLC) …
[PDF][PDF] Second-line nintedanib+ docetaxel for patients with lung adenocarcinoma after failure on first-line immune checkpoint inhibitor combination therapy: initial …
C Grohé, T Wehler, T Dechow, S Henschke… - Presented at the …, 2020 - inoncology.es
• Treatment of advanced non-small cell lung cancer (NSCLC) has undergone significant
changes, with immune checkpoint inhibitors (ICIs) alone, or in combination with chemotherapy, …
changes, with immune checkpoint inhibitors (ICIs) alone, or in combination with chemotherapy, …
Lamina propria T cell activation: role of the costimulatory molecule CD2 and its cytoplasmic tail for the regulation of proliferation and apoptosis
S Henschke, NN Pawlowski, MK Wild… - International journal of …, 2006 - Springer
Background/aims Accumulation of T lymphocytes in the gut is a hallmark of inflammatory
bowel disease probably caused by insufficient T cell apoptosis. Activated peripheral T cells, or “…
bowel disease probably caused by insufficient T cell apoptosis. Activated peripheral T cells, or “…
Impact of PD-L1 and KRAS status on the efficacy of nintedanib (NIN) + docetaxel (DOC) following treatment with first-line immune checkpoint inhibitor (ICI) + …
C Grohé, T Wehler, S Henschke, S Hammerschmidt… - 2023 - ascopubs.org
e21149 Background: The identification of targetable molecular tumor markers in patients (pts)
with NSCLC has increased significantly over the past decades and has resulted in …
with NSCLC has increased significantly over the past decades and has resulted in …
Effect of performance status (ECOG PS) on treatment outcome with second-line (2L) nintedanib (NIN)+ docetaxel (DOC) for patients (pts) with lung adenocarcinoma …
C Grohé, T Wehler, S Henschke, I Dittrich… - 2022 - ascopubs.org
9092 Background: ICIs with or without chemotherapy represent 1L standard of care for patients
with advanced non-small cell lung cancer (NSCLC) without targetable driver mutations. …
with advanced non-small cell lung cancer (NSCLC) without targetable driver mutations. …
Amphetamine induced eosinophilic pneumonia: A case report
K Rososinska, S Henschke… - European Respiratory …, 2014 - Eur Respiratory Soc
Idiopathic acute eosinophilic pneumonia is a rare disease. It presents with acute febrile
illness, respiratory insufficiency, pulmonary infiltration and high eosinophil levels in broncho …
illness, respiratory insufficiency, pulmonary infiltration and high eosinophil levels in broncho …
Successful treatment of alveolar proteinosis by inhaled GM-CSF and intravenous rituximab
S Fähndrich, P Lepper, S Henschke… - European …, 2014 - Eur Respiratory Soc
We report a case of successful treatment of alveolar proteinosis by a combination of inhaled
GM-CSF and intravenous administration of rituximab, a monoclonal antibody directed …
GM-CSF and intravenous administration of rituximab, a monoclonal antibody directed …
Septic shock–A contraindication for bridge to transplant?
…, I Stehle, K Rentz, S Henschke… - European …, 2014 - Eur Respiratory Soc
Aim: To show first results of patients in septic shock being bridged to lung transplantation (ltx)
via extra corporal membrane oxygenation (ECMO). Methods: A retrospective, single-center …
via extra corporal membrane oxygenation (ECMO). Methods: A retrospective, single-center …
[CITATION][C] Bilateral Treatment With Endobronchial Valves For Endoscopic Lung Volume Reduction
…, H Wilkens, S Fahndrich, S Henschke… - B46. CASINO …, 2014 - atsjournals.org
1 the 2nd EBV implantation was betrug 26.1±8.3% pred.(+ 15%) at a RV of 276.1±41.8%
pred.(-10%). 6-MWT was 338.5±75 m (+ 43%). After bilateral treatment, mean FEV was 28.4±…
pred.(-10%). 6-MWT was 338.5±75 m (+ 43%). After bilateral treatment, mean FEV was 28.4±…
[CITATION][C] Mechanisms of CD2 mediated apoptosis of human lamina propria T lymphocytes
JC Hoffmann, S Henschke, K Peters, B Herrmann… - Gastroenterology, 2000 - infona.pl
… Hoffmann, Sven Henschke, Karsten Peters, Birgit Herrmann, Martin Zeitz …